Guardant Health
GH
#1106
Rank
A$30.91 B
Marketcap
A$228.48
Share price
-0.96%
Change (1 day)
51.72%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): A-$7.40

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is A-$5.07. In 2022 the company made an earnings per share (EPS) of A-$9.30 a decrease over its 2021 EPS that were of A-$5.81.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$7.40-20.4%
2022A-$9.3060%
2021A-$5.8155.04%
2020A-$3.75207.14%
2019A-$1.22-19.81%
2018A-$1.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
A-$0.36-92.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A-$3.56-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA